APYX MEDICAL CORPORATION's ticker is APYX and the CUSIP is 03837C106. A total of 52 filers reported holding APYX MEDICAL CORPORATION in Q1 2024. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $15,761 | -6.8% | 11,762 | -5.4% | 0.00% | – |
| Q1 2024 | $16,905 | -63.1% | 12,430 | -29.0% | 0.00% | – |
| Q4 2023 | $45,874 | -7.2% | 17,509 | +13.4% | 0.00% | – |
| Q3 2023 | $49,414 | -3.2% | 15,442 | +52.2% | 0.00% | – |
| Q2 2023 | $51,049 | +64.1% | 10,149 | -6.0% | 0.00% | – |
| Q1 2023 | $31,107 | +13.1% | 10,801 | -8.1% | 0.00% | – |
| Q4 2022 | $27,493 | -47.1% | 11,749 | +0.6% | 0.00% | – |
| Q3 2022 | $52,000 | -22.4% | 11,682 | +2.1% | 0.00% | – |
| Q2 2022 | $67,000 | -39.6% | 11,443 | -32.5% | 0.00% | – |
| Q1 2022 | $111,000 | -51.1% | 16,942 | -4.5% | 0.00% | – |
| Q4 2021 | $227,000 | -6.6% | 17,738 | +1.0% | 0.00% | – |
| Q3 2021 | $243,000 | – | 17,555 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invenire Partners, LP | 410,999 | $2,683,823,000 | 3.37% |
| Archon Capital Management LLC | 2,333,589 | $15,238,000 | 1.88% |
| COWEN AND COMPANY, LLC | 2,634,003 | $17,200,000 | 1.66% |
| Taylor Frigon Capital Management LLC | 510,094 | $3,331,000 | 1.24% |
| Cowen Prime Advisors LLC | 253,859 | $1,658,000 | 0.70% |
| Millrace Asset Group, Inc. | 126,024 | $823,000 | 0.60% |
| Kent Lake Capital LLC | 134,994 | $882,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,398,279 | $22,191,000 | 0.46% |
| GREENWOOD CAPITAL ASSOCIATES LLC | 144,293 | $942,000 | 0.25% |
| PURA VIDA INVESTMENTS, LLC | 982,683 | $6,417,000 | 0.21% |